About Paul August
Paul August is a co-founder and director at AcuraStem.
Paul August first appears on SEC filings in 2018.
Experience
This experience comes from Paul August's profile and from SEC filings. For roles taken from filings, the years are when the filings name Paul August in the role, so the role may have started earlier or lasted longer.
RT
ReviR Therapeutics Current
Chief Scientific Officer
2022 – Present
AcuraStem Inc Current
Co-founder and director
2016 – Present · Pasadena, CA
Develops treatments for people with ALS, frontotemporal dementia and other neurodegenerative diseases.
AP
Agios Pharmaceuticals
Vice President, Genetically Defined Disease Biology
2020 – 2022
LP
Ligand Pharmaceuticals
Vice President
2020
IC
Icagen
Vice President
2016 – 2020
UT
University of Arizona College of Medicine – Tucson
Adjunct Faculty Member
2016 – 2020
SA
Sanofi
Senior Director
2010 – 2016
SA
Sanofi-Aventis
Senior Manager
2005 – 2010
AV
Aventis
Principal Investigator
2000 – 2004
AP
Ariad Pharmaceuticals
Senior Scientist
1998 – 2000
MS
MDS Pharma Services
Senior Scientist
1997 – 1998
MP
MDS Panlabs
Scientist
1997 – 1998
SH
State of New Hampshire
House of Representatives
1985 – 1986
Key Colleagues at Startups
The people Paul August works with at each company, as listed on that company's latest Form D.
AcuraStem Inc · Form D, Jun 22, 2026
Samuel Alworth
Co-founder and CEO, director
QM
Qing Liu-Michael
Director
Marcel van der Brug
Chief Scientific Officer
Justin Ichida
Co-founder and director